+44 20 8123 2220
+1 732 587 5005
info@marketpublishers.com
Market Research Reports > Medicine, Pharmaceuticals & Biotechnology > Healthcare Equipment & Services > Withdrawal of Rimonabant and Sibutramine Create High Unmet Need in Obesity Market

Withdrawal of Rimonabant and Sibutramine Create High Unmet Need in Obesity Market

Ask a question
Date: December 1, 2010
Pages: 4
Price:
US$ 500.00
License: What are the licenses types for electronic versions?
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: W1C035C5D7FEN

Download PDF Leaflet

Withdrawal of Rimonabant and Sibutramine Create High Unmet Need in Obesity Market

Summary

GlobalData’s report, “Withdrawal of Rimonabant and Sibutramine Create High Unmet Need in Obesity Market” provides key data, information on Obesity therapy Market.

Scope
  • Data and information on Obesity Market and current line of therapy including Unmet Need analysis
Reasons to buy
  • Develop business strategies by understanding the trends and developments in anti obesity market

Contents

1 TABLE OF CONTENTS

1.1 List of Tables

2 SUMMARY

3 OBESITY

3.1 Overview
3.2 Management of Obesity
  3.2.1 Treatment regimen for treating obesity includes:
3.3 Opportunity and Unmet Need
3.4 Market Impact on Withdrawal of Rimonabant and Sibutramine

4 APPENDIX

4.1 Methodology
  4.1.1 Coverage
  4.1.2 Secondary Research
  4.1.3 Primary Research
  4.1.4 Expert Panel Validation
4.2 Contact Us
4.3 Disclaimer

LIST OF TABLES

Table 1: Classification Of Overweight and Obesity By BMI Skip to top

Ask Your Question

Withdrawal of Rimonabant and Sibutramine Create High Unmet Need in Obesity Market
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:

MarketPublishers.com, 2006-2012
All Rights Reserved